CLARUS THERAPEUTICS HOLDINGS, INC.: cashflow_financing

Value{"amount": 59333480, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2020-05-22 – 2020-12-31
Statuscurrent
EntityCLARUS THERAPEUTICS HOLDINGS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-21-024924 · Open the official SEC filing →
Retrieved: 2026-08-19T18:16:48.630383+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001817944/cashflow-financing/2020-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b4ea4c96-9c98-449e-af04-c2d30d78ebf5

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies